Lipocalin 2 inhibits the expressions of interleukin-8 and macrophage inflammatory protein-1α in human neutrophil-like cells
- 1 February 2025
- journal article
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (1) , 100624
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 30 references indexed in Scilit:
- The Role of CCL3 in the Pathogenesis of Rheumatoid ArthritisRheumatology and Therapy, 2023
- Interleukin-8: An evolving chemokineCytokine, 2022
- Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppressionPharmacology & Therapeutics, 2020
- MIP-1α and MCP-1 as salivary biomarkers in periodontal diseaseThe Saudi Dental Journal, 2018
- Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine SecretionJournal of Investigative Dermatology, 2016
- The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albuminDiabetes Research and Clinical Practice, 2014
- A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron UptakeCell, 2005
- Macrophage inflammatory protein-1The International Journal of Biochemistry & Cell Biology, 2004
- Molecular Characterization and Pattern of Tissue Expression of the Gene for Neutrophil Gelatinase-Associated Lipocalin from HumansGenomics, 1997
- Interleukin‐8, a chemotactic and inflammatory cytokineFEBS Letters, 1992